{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:21:43Z","timestamp":1773296503036,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ijpharm.2011.10.030","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T21:24:55Z","timestamp":1319491495000},"page":"75-82","source":"Crossref","is-referenced-by-count":17,"title":["Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate"],"prefix":"10.1016","volume":"422","author":[{"given":"V.N.P.","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bierend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Robins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Steckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Flament","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.10.030_bib0005","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1007\/s11095-006-9082-6","article-title":"Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation","volume":"23","author":"Adi","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejps.2010.11.008","article-title":"Structural influence of cohesive mixtures of salbutamol sulphate and lactose on aerosolisation and de-agglomeration behaviour under dynamic conditions","volume":"42","author":"Behara","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0020","first-page":"179","article-title":"Dry powder inhalation technology","author":"Bell","year":"1994","journal-title":"Pharm. Manufact. Int."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(98)00179-3","article-title":"Determination of surface properties and flow characteristics of salbutamol sulphate, before and after micronisation","volume":"172","author":"Feeley","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2007.06.041","article-title":"Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations","volume":"348","author":"Guchardi","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijpharm.2009.07.002","article-title":"Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design","volume":"380","author":"Guenette","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0040","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1208\/s12249-009-9313-3","article-title":"Effect of particle shape on dry particle inhalation: study of flowability, aerosolization, and deposition properties","volume":"10","author":"Hassan","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0032-5910(75)80021-0","article-title":"Ordered mixing: a new concept in powder mixing practice","volume":"11","author":"Hersey","year":"1975","journal-title":"Powder Technol."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1163\/016942410X525506","article-title":"Computing the surface energy distributions of heterogeneous crystalline powders","volume":"25","author":"Jefferson","year":"2011","journal-title":"J. Adhes. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0055","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s11095-006-9012-7","article-title":"The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations","volume":"23","author":"Jones","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0060","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1248\/cpb.54.1508","article-title":"Novel approach to DPI carrier lactose with mechanofusion process with additives and evaluation by IGC","volume":"54","author":"Kumon","year":"2006","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00164-7","article-title":"The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate","volume":"191","author":"Larhrib","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0070","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1023\/A:1020464801786","article-title":"Particle interactions involved in aerosol dispersion of ternary interactive mixtures","volume":"19","author":"Louey","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(02)00621-X","article-title":"Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures","volume":"252","author":"Louey","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0080","first-page":"243","article-title":"The role of fine particle excipients in pharmaceutical dry powder aerosols","author":"Lucas","year":"1998","journal-title":"Proc. Respir. Drug Deliv. VI"},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0085","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1023\/A:1011977826711","article-title":"Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers","volume":"15","author":"Lucas","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5173(01)00589-0","article-title":"The use of inverse phase gas chromatography to study the change of surface energy of amorphous lactose as a function of relative humidity and the processes of collapse and crystallisation","volume":"217","author":"Newell","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0100","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s11095-008-9538-y","article-title":"The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations","volume":"25","author":"Shur","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0105","first-page":"15","article-title":"Inhalation powders\u2014a simple dosage form for pulmonary delivery?","volume":"9","author":"Steckel","year":"2002","journal-title":"Swiss Pharma"},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejpb.2003.12.003","article-title":"Functionality testing of inhalation grade lactose","volume":"57","author":"Steckel","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijpharm.2005.10.043","article-title":"Effect of milling and sieving on functionality of dry powder inhalation products","volume":"309","author":"Steckel","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-409X(97)00510-3","article-title":"Review of dry powder inhalers","volume":"26","author":"Sumby","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0125","first-page":"1","article-title":"Formulation of lactose for inhaled delivery systems","volume":"11","author":"te Wierik","year":"2002","journal-title":"Pharm. Technol. Eur."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jps.20519","article-title":"Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography","volume":"95","author":"Tong","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0135","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1002\/jps.22100","article-title":"Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate","volume":"99","author":"Xu","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0378-5173(98)00247-6","article-title":"Characterisation of the surface energetics of milled dl-propranolol hydrochloride using inverse gas chromatography and molecular modelling","volume":"174","author":"York","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2005.02.004","article-title":"The influence of dose on the performance of dry powder inhalation systems","volume":"296","author":"Young","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.030_bib0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0378-5173(98)00300-7","article-title":"The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro","volume":"176","author":"Zeng","year":"1998","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311009690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311009690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T01:52:48Z","timestamp":1543456368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311009690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0378517311009690"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.10.030","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}